Global Oncology Small Molecule Drugs Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Oncology Small Molecule Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Oncology Small Molecule Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Oncology Small Molecule Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Oncology Small Molecule Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oncology Small Molecule Drugs market, reaching US$ million by the year 2028. As for the Europe Oncology Small Molecule Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oncology Small Molecule Drugs players cover Roche, Novartis, Pfizer, and Celgene, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Small Molecule Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
As the global economy mends, the 2021 growth of Oncology Small Molecule Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Oncology Small Molecule Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Oncology Small Molecule Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Oncology Small Molecule Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oncology Small Molecule Drugs market, reaching US$ million by the year 2028. As for the Europe Oncology Small Molecule Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oncology Small Molecule Drugs players cover Roche, Novartis, Pfizer, and Celgene, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Small Molecule Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Chemotherapy Drugs
- Immunomodulating Drugs
- Targeted Therapy Drugs
- Hormonal Therapy
- Other
- Blood Cancer
- Breast Cancer
- Gastrointestinal Cancer
- Prostate Cancer
- Lung Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Novartis
- Pfizer
- Celgene
- Bristol-Myers Squibb
- Amgen
- Johnson & Johnson
- AbbVie
- Sanofi
- Takeda
- Eli Lilly
- Bayer
- AstraZeneca
- Astellas
- Merck
- Biogen Idec
- Eisai
- Teva
- Otsuka
- Ipsen
- Gilead Sciences
- Exelixis
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Small Molecule Drugs Market Size 2017-2028
2.1.2 Oncology Small Molecule Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Oncology Small Molecule Drugs Segment by Type
2.2.1 Chemotherapy Drugs
2.2.2 Immunomodulating Drugs
2.2.3 Targeted Therapy Drugs
2.2.4 Hormonal Therapy
2.2.5 Other
2.3 Oncology Small Molecule Drugs Market Size by Type
2.3.1 Oncology Small Molecule Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2022)
2.4 Oncology Small Molecule Drugs Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Lung Cancer
2.4.6 Other
2.5 Oncology Small Molecule Drugs Market Size by Application
2.5.1 Oncology Small Molecule Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2022)
3 ONCOLOGY SMALL MOLECULE DRUGS MARKET SIZE BY PLAYER
3.1 Oncology Small Molecule Drugs Market Size Market Share by Players
3.1.1 Global Oncology Small Molecule Drugs Revenue by Players (2020-2022)
3.1.2 Global Oncology Small Molecule Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Oncology Small Molecule Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLOGY SMALL MOLECULE DRUGS BY REGIONS
4.1 Oncology Small Molecule Drugs Market Size by Regions (2017-2022)
4.2 Americas Oncology Small Molecule Drugs Market Size Growth (2017-2022)
4.3 APAC Oncology Small Molecule Drugs Market Size Growth (2017-2022)
4.4 Europe Oncology Small Molecule Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Oncology Small Molecule Drugs Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Oncology Small Molecule Drugs Market Size by Country (2017-2022)
5.2 Americas Oncology Small Molecule Drugs Market Size by Type (2017-2022)
5.3 Americas Oncology Small Molecule Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Small Molecule Drugs Market Size by Region (2017-2022)
6.2 APAC Oncology Small Molecule Drugs Market Size by Type (2017-2022)
6.3 APAC Oncology Small Molecule Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncology Small Molecule Drugs by Country (2017-2022)
7.2 Europe Oncology Small Molecule Drugs Market Size by Type (2017-2022)
7.3 Europe Oncology Small Molecule Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Small Molecule Drugs by Region (2017-2022)
8.2 Middle East & Africa Oncology Small Molecule Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Oncology Small Molecule Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLOGY SMALL MOLECULE DRUGS MARKET FORECAST
10.1 Global Oncology Small Molecule Drugs Forecast by Regions (2023-2028)
10.1.1 Global Oncology Small Molecule Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Oncology Small Molecule Drugs Forecast
10.1.3 APAC Oncology Small Molecule Drugs Forecast
10.1.4 Europe Oncology Small Molecule Drugs Forecast
10.1.5 Middle East & Africa Oncology Small Molecule Drugs Forecast
10.2 Americas Oncology Small Molecule Drugs Forecast by Country (2023-2028)
10.2.1 United States Oncology Small Molecule Drugs Market Forecast
10.2.2 Canada Oncology Small Molecule Drugs Market Forecast
10.2.3 Mexico Oncology Small Molecule Drugs Market Forecast
10.2.4 Brazil Oncology Small Molecule Drugs Market Forecast
10.3 APAC Oncology Small Molecule Drugs Forecast by Region (2023-2028)
10.3.1 China Oncology Small Molecule Drugs Market Forecast
10.3.2 Japan Oncology Small Molecule Drugs Market Forecast
10.3.3 Korea Oncology Small Molecule Drugs Market Forecast
10.3.4 Southeast Asia Oncology Small Molecule Drugs Market Forecast
10.3.5 India Oncology Small Molecule Drugs Market Forecast
10.3.6 Australia Oncology Small Molecule Drugs Market Forecast
10.4 Europe Oncology Small Molecule Drugs Forecast by Country (2023-2028)
10.4.1 Germany Oncology Small Molecule Drugs Market Forecast
10.4.2 France Oncology Small Molecule Drugs Market Forecast
10.4.3 UK Oncology Small Molecule Drugs Market Forecast
10.4.4 Italy Oncology Small Molecule Drugs Market Forecast
10.4.5 Russia Oncology Small Molecule Drugs Market Forecast
10.5 Middle East & Africa Oncology Small Molecule Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Oncology Small Molecule Drugs Market Forecast
10.5.2 South Africa Oncology Small Molecule Drugs Market Forecast
10.5.3 Israel Oncology Small Molecule Drugs Market Forecast
10.5.4 Turkey Oncology Small Molecule Drugs Market Forecast
10.5.5 GCC Countries Oncology Small Molecule Drugs Market Forecast
10.6 Global Oncology Small Molecule Drugs Forecast by Type (2023-2028)
10.7 Global Oncology Small Molecule Drugs Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Oncology Small Molecule Drugs Product Offered
11.1.3 Roche Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Oncology Small Molecule Drugs Product Offered
11.2.3 Novartis Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Oncology Small Molecule Drugs Product Offered
11.3.3 Pfizer Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Celgene
11.4.1 Celgene Company Information
11.4.2 Celgene Oncology Small Molecule Drugs Product Offered
11.4.3 Celgene Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Celgene Main Business Overview
11.4.5 Celgene Latest Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Information
11.5.2 Bristol-Myers Squibb Oncology Small Molecule Drugs Product Offered
11.5.3 Bristol-Myers Squibb Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Bristol-Myers Squibb Main Business Overview
11.5.5 Bristol-Myers Squibb Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Oncology Small Molecule Drugs Product Offered
11.6.3 Amgen Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Information
11.7.2 Johnson & Johnson Oncology Small Molecule Drugs Product Offered
11.7.3 Johnson & Johnson Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Johnson & Johnson Main Business Overview
11.7.5 Johnson & Johnson Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Oncology Small Molecule Drugs Product Offered
11.8.3 AbbVie Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Oncology Small Molecule Drugs Product Offered
11.9.3 Sanofi Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Oncology Small Molecule Drugs Product Offered
11.10.3 Takeda Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Company Information
11.11.2 Eli Lilly Oncology Small Molecule Drugs Product Offered
11.11.3 Eli Lilly Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Eli Lilly Main Business Overview
11.11.5 Eli Lilly Latest Developments
11.12 Bayer
11.12.1 Bayer Company Information
11.12.2 Bayer Oncology Small Molecule Drugs Product Offered
11.12.3 Bayer Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Bayer Main Business Overview
11.12.5 Bayer Latest Developments
11.13 AstraZeneca
11.13.1 AstraZeneca Company Information
11.13.2 AstraZeneca Oncology Small Molecule Drugs Product Offered
11.13.3 AstraZeneca Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 AstraZeneca Main Business Overview
11.13.5 AstraZeneca Latest Developments
11.14 Astellas
11.14.1 Astellas Company Information
11.14.2 Astellas Oncology Small Molecule Drugs Product Offered
11.14.3 Astellas Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Astellas Main Business Overview
11.14.5 Astellas Latest Developments
11.15 Merck
11.15.1 Merck Company Information
11.15.2 Merck Oncology Small Molecule Drugs Product Offered
11.15.3 Merck Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Merck Main Business Overview
11.15.5 Merck Latest Developments
11.16 Biogen Idec
11.16.1 Biogen Idec Company Information
11.16.2 Biogen Idec Oncology Small Molecule Drugs Product Offered
11.16.3 Biogen Idec Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Biogen Idec Main Business Overview
11.16.5 Biogen Idec Latest Developments
11.17 Eisai
11.17.1 Eisai Company Information
11.17.2 Eisai Oncology Small Molecule Drugs Product Offered
11.17.3 Eisai Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Eisai Main Business Overview
11.17.5 Eisai Latest Developments
11.18 Teva
11.18.1 Teva Company Information
11.18.2 Teva Oncology Small Molecule Drugs Product Offered
11.18.3 Teva Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Teva Main Business Overview
11.18.5 Teva Latest Developments
11.19 Otsuka
11.19.1 Otsuka Company Information
11.19.2 Otsuka Oncology Small Molecule Drugs Product Offered
11.19.3 Otsuka Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Otsuka Main Business Overview
11.19.5 Otsuka Latest Developments
11.20 Ipsen
11.20.1 Ipsen Company Information
11.20.2 Ipsen Oncology Small Molecule Drugs Product Offered
11.20.3 Ipsen Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Ipsen Main Business Overview
11.20.5 Ipsen Latest Developments
11.21 Gilead Sciences
11.21.1 Gilead Sciences Company Information
11.21.2 Gilead Sciences Oncology Small Molecule Drugs Product Offered
11.21.3 Gilead Sciences Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Gilead Sciences Main Business Overview
11.21.5 Gilead Sciences Latest Developments
11.22 Exelixis
11.22.1 Exelixis Company Information
11.22.2 Exelixis Oncology Small Molecule Drugs Product Offered
11.22.3 Exelixis Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Exelixis Main Business Overview
11.22.5 Exelixis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Small Molecule Drugs Market Size 2017-2028
2.1.2 Oncology Small Molecule Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Oncology Small Molecule Drugs Segment by Type
2.2.1 Chemotherapy Drugs
2.2.2 Immunomodulating Drugs
2.2.3 Targeted Therapy Drugs
2.2.4 Hormonal Therapy
2.2.5 Other
2.3 Oncology Small Molecule Drugs Market Size by Type
2.3.1 Oncology Small Molecule Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2022)
2.4 Oncology Small Molecule Drugs Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Lung Cancer
2.4.6 Other
2.5 Oncology Small Molecule Drugs Market Size by Application
2.5.1 Oncology Small Molecule Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2022)
3 ONCOLOGY SMALL MOLECULE DRUGS MARKET SIZE BY PLAYER
3.1 Oncology Small Molecule Drugs Market Size Market Share by Players
3.1.1 Global Oncology Small Molecule Drugs Revenue by Players (2020-2022)
3.1.2 Global Oncology Small Molecule Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Oncology Small Molecule Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLOGY SMALL MOLECULE DRUGS BY REGIONS
4.1 Oncology Small Molecule Drugs Market Size by Regions (2017-2022)
4.2 Americas Oncology Small Molecule Drugs Market Size Growth (2017-2022)
4.3 APAC Oncology Small Molecule Drugs Market Size Growth (2017-2022)
4.4 Europe Oncology Small Molecule Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Oncology Small Molecule Drugs Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Oncology Small Molecule Drugs Market Size by Country (2017-2022)
5.2 Americas Oncology Small Molecule Drugs Market Size by Type (2017-2022)
5.3 Americas Oncology Small Molecule Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Small Molecule Drugs Market Size by Region (2017-2022)
6.2 APAC Oncology Small Molecule Drugs Market Size by Type (2017-2022)
6.3 APAC Oncology Small Molecule Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncology Small Molecule Drugs by Country (2017-2022)
7.2 Europe Oncology Small Molecule Drugs Market Size by Type (2017-2022)
7.3 Europe Oncology Small Molecule Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Small Molecule Drugs by Region (2017-2022)
8.2 Middle East & Africa Oncology Small Molecule Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Oncology Small Molecule Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLOGY SMALL MOLECULE DRUGS MARKET FORECAST
10.1 Global Oncology Small Molecule Drugs Forecast by Regions (2023-2028)
10.1.1 Global Oncology Small Molecule Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Oncology Small Molecule Drugs Forecast
10.1.3 APAC Oncology Small Molecule Drugs Forecast
10.1.4 Europe Oncology Small Molecule Drugs Forecast
10.1.5 Middle East & Africa Oncology Small Molecule Drugs Forecast
10.2 Americas Oncology Small Molecule Drugs Forecast by Country (2023-2028)
10.2.1 United States Oncology Small Molecule Drugs Market Forecast
10.2.2 Canada Oncology Small Molecule Drugs Market Forecast
10.2.3 Mexico Oncology Small Molecule Drugs Market Forecast
10.2.4 Brazil Oncology Small Molecule Drugs Market Forecast
10.3 APAC Oncology Small Molecule Drugs Forecast by Region (2023-2028)
10.3.1 China Oncology Small Molecule Drugs Market Forecast
10.3.2 Japan Oncology Small Molecule Drugs Market Forecast
10.3.3 Korea Oncology Small Molecule Drugs Market Forecast
10.3.4 Southeast Asia Oncology Small Molecule Drugs Market Forecast
10.3.5 India Oncology Small Molecule Drugs Market Forecast
10.3.6 Australia Oncology Small Molecule Drugs Market Forecast
10.4 Europe Oncology Small Molecule Drugs Forecast by Country (2023-2028)
10.4.1 Germany Oncology Small Molecule Drugs Market Forecast
10.4.2 France Oncology Small Molecule Drugs Market Forecast
10.4.3 UK Oncology Small Molecule Drugs Market Forecast
10.4.4 Italy Oncology Small Molecule Drugs Market Forecast
10.4.5 Russia Oncology Small Molecule Drugs Market Forecast
10.5 Middle East & Africa Oncology Small Molecule Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Oncology Small Molecule Drugs Market Forecast
10.5.2 South Africa Oncology Small Molecule Drugs Market Forecast
10.5.3 Israel Oncology Small Molecule Drugs Market Forecast
10.5.4 Turkey Oncology Small Molecule Drugs Market Forecast
10.5.5 GCC Countries Oncology Small Molecule Drugs Market Forecast
10.6 Global Oncology Small Molecule Drugs Forecast by Type (2023-2028)
10.7 Global Oncology Small Molecule Drugs Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Oncology Small Molecule Drugs Product Offered
11.1.3 Roche Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Oncology Small Molecule Drugs Product Offered
11.2.3 Novartis Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Oncology Small Molecule Drugs Product Offered
11.3.3 Pfizer Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Celgene
11.4.1 Celgene Company Information
11.4.2 Celgene Oncology Small Molecule Drugs Product Offered
11.4.3 Celgene Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Celgene Main Business Overview
11.4.5 Celgene Latest Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Information
11.5.2 Bristol-Myers Squibb Oncology Small Molecule Drugs Product Offered
11.5.3 Bristol-Myers Squibb Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Bristol-Myers Squibb Main Business Overview
11.5.5 Bristol-Myers Squibb Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Oncology Small Molecule Drugs Product Offered
11.6.3 Amgen Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Company Information
11.7.2 Johnson & Johnson Oncology Small Molecule Drugs Product Offered
11.7.3 Johnson & Johnson Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Johnson & Johnson Main Business Overview
11.7.5 Johnson & Johnson Latest Developments
11.8 AbbVie
11.8.1 AbbVie Company Information
11.8.2 AbbVie Oncology Small Molecule Drugs Product Offered
11.8.3 AbbVie Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 AbbVie Main Business Overview
11.8.5 AbbVie Latest Developments
11.9 Sanofi
11.9.1 Sanofi Company Information
11.9.2 Sanofi Oncology Small Molecule Drugs Product Offered
11.9.3 Sanofi Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Sanofi Main Business Overview
11.9.5 Sanofi Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Oncology Small Molecule Drugs Product Offered
11.10.3 Takeda Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Company Information
11.11.2 Eli Lilly Oncology Small Molecule Drugs Product Offered
11.11.3 Eli Lilly Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Eli Lilly Main Business Overview
11.11.5 Eli Lilly Latest Developments
11.12 Bayer
11.12.1 Bayer Company Information
11.12.2 Bayer Oncology Small Molecule Drugs Product Offered
11.12.3 Bayer Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Bayer Main Business Overview
11.12.5 Bayer Latest Developments
11.13 AstraZeneca
11.13.1 AstraZeneca Company Information
11.13.2 AstraZeneca Oncology Small Molecule Drugs Product Offered
11.13.3 AstraZeneca Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 AstraZeneca Main Business Overview
11.13.5 AstraZeneca Latest Developments
11.14 Astellas
11.14.1 Astellas Company Information
11.14.2 Astellas Oncology Small Molecule Drugs Product Offered
11.14.3 Astellas Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Astellas Main Business Overview
11.14.5 Astellas Latest Developments
11.15 Merck
11.15.1 Merck Company Information
11.15.2 Merck Oncology Small Molecule Drugs Product Offered
11.15.3 Merck Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Merck Main Business Overview
11.15.5 Merck Latest Developments
11.16 Biogen Idec
11.16.1 Biogen Idec Company Information
11.16.2 Biogen Idec Oncology Small Molecule Drugs Product Offered
11.16.3 Biogen Idec Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Biogen Idec Main Business Overview
11.16.5 Biogen Idec Latest Developments
11.17 Eisai
11.17.1 Eisai Company Information
11.17.2 Eisai Oncology Small Molecule Drugs Product Offered
11.17.3 Eisai Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Eisai Main Business Overview
11.17.5 Eisai Latest Developments
11.18 Teva
11.18.1 Teva Company Information
11.18.2 Teva Oncology Small Molecule Drugs Product Offered
11.18.3 Teva Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Teva Main Business Overview
11.18.5 Teva Latest Developments
11.19 Otsuka
11.19.1 Otsuka Company Information
11.19.2 Otsuka Oncology Small Molecule Drugs Product Offered
11.19.3 Otsuka Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Otsuka Main Business Overview
11.19.5 Otsuka Latest Developments
11.20 Ipsen
11.20.1 Ipsen Company Information
11.20.2 Ipsen Oncology Small Molecule Drugs Product Offered
11.20.3 Ipsen Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Ipsen Main Business Overview
11.20.5 Ipsen Latest Developments
11.21 Gilead Sciences
11.21.1 Gilead Sciences Company Information
11.21.2 Gilead Sciences Oncology Small Molecule Drugs Product Offered
11.21.3 Gilead Sciences Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Gilead Sciences Main Business Overview
11.21.5 Gilead Sciences Latest Developments
11.22 Exelixis
11.22.1 Exelixis Company Information
11.22.2 Exelixis Oncology Small Molecule Drugs Product Offered
11.22.3 Exelixis Oncology Small Molecule Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Exelixis Main Business Overview
11.22.5 Exelixis Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oncology Small Molecule Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Chemotherapy Drugs
Table 3. Major Players of Immunomodulating Drugs
Table 4. Major Players of Targeted Therapy Drugs
Table 5. Major Players of Hormonal Therapy
Table 6. Major Players of Other
Table 7. Oncology Small Molecule Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Oncology Small Molecule Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2022)
Table 10. Oncology Small Molecule Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Oncology Small Molecule Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2022)
Table 13. Global Oncology Small Molecule Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Oncology Small Molecule Drugs Revenue Market Share by Player (2020-2022)
Table 15. Oncology Small Molecule Drugs Key Players Head office and Products Offered
Table 16. Oncology Small Molecule Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oncology Small Molecule Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Oncology Small Molecule Drugs Market Size Market Share by Regions (2017-2022)
Table 21. Americas Oncology Small Molecule Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Oncology Small Molecule Drugs Market Size Market Share by Country (2017-2022)
Table 23. Americas Oncology Small Molecule Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2022)
Table 25. Americas Oncology Small Molecule Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2022)
Table 27. APAC Oncology Small Molecule Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Oncology Small Molecule Drugs Market Size Market Share by Region (2017-2022)
Table 29. APAC Oncology Small Molecule Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2022)
Table 31. APAC Oncology Small Molecule Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2022)
Table 33. Europe Oncology Small Molecule Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Oncology Small Molecule Drugs Market Size Market Share by Country (2017-2022)
Table 35. Europe Oncology Small Molecule Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2022)
Table 37. Europe Oncology Small Molecule Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Oncology Small Molecule Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Oncology Small Molecule Drugs Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Oncology Small Molecule Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Oncology Small Molecule Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Oncology Small Molecule Drugs
Table 46. Key Market Challenges & Risks of Oncology Small Molecule Drugs
Table 47. Key Industry Trends of Oncology Small Molecule Drugs
Table 48. Global Oncology Small Molecule Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Oncology Small Molecule Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Oncology Small Molecule Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Oncology Small Molecule Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Oncology Small Molecule Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Oncology Small Molecule Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 54. Roche Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 55. Roche Oncology Small Molecule Drugs Product Offered
Table 56. Roche Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Roche Main Business
Table 58. Roche Latest Developments
Table 59. Novartis Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 60. Novartis Oncology Small Molecule Drugs Product Offered
Table 61. Novartis Main Business
Table 62. Novartis Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Novartis Latest Developments
Table 64. Pfizer Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 65. Pfizer Oncology Small Molecule Drugs Product Offered
Table 66. Pfizer Main Business
Table 67. Pfizer Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Pfizer Latest Developments
Table 69. Celgene Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 70. Celgene Oncology Small Molecule Drugs Product Offered
Table 71. Celgene Main Business
Table 72. Celgene Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Celgene Latest Developments
Table 74. Bristol-Myers Squibb Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 75. Bristol-Myers Squibb Oncology Small Molecule Drugs Product Offered
Table 76. Bristol-Myers Squibb Main Business
Table 77. Bristol-Myers Squibb Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Bristol-Myers Squibb Latest Developments
Table 79. Amgen Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 80. Amgen Oncology Small Molecule Drugs Product Offered
Table 81. Amgen Main Business
Table 82. Amgen Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Amgen Latest Developments
Table 84. Johnson & Johnson Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 85. Johnson & Johnson Oncology Small Molecule Drugs Product Offered
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Johnson & Johnson Latest Developments
Table 89. AbbVie Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 90. AbbVie Oncology Small Molecule Drugs Product Offered
Table 91. AbbVie Main Business
Table 92. AbbVie Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. AbbVie Latest Developments
Table 94. Sanofi Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 95. Sanofi Oncology Small Molecule Drugs Product Offered
Table 96. Sanofi Main Business
Table 97. Sanofi Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Sanofi Latest Developments
Table 99. Takeda Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 100. Takeda Oncology Small Molecule Drugs Product Offered
Table 101. Takeda Main Business
Table 102. Takeda Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Takeda Latest Developments
Table 104. Eli Lilly Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 105. Eli Lilly Oncology Small Molecule Drugs Product Offered
Table 106. Eli Lilly Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 107. Eli Lilly Main Business
Table 108. Eli Lilly Latest Developments
Table 109. Bayer Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 110. Bayer Oncology Small Molecule Drugs Product Offered
Table 111. Bayer Main Business
Table 112. Bayer Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 113. Bayer Latest Developments
Table 114. AstraZeneca Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 115. AstraZeneca Oncology Small Molecule Drugs Product Offered
Table 116. AstraZeneca Main Business
Table 117. AstraZeneca Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. AstraZeneca Latest Developments
Table 119. Astellas Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 120. Astellas Oncology Small Molecule Drugs Product Offered
Table 121. Astellas Main Business
Table 122. Astellas Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. Astellas Latest Developments
Table 124. Merck Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 125. Merck Oncology Small Molecule Drugs Product Offered
Table 126. Merck Main Business
Table 127. Merck Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. Merck Latest Developments
Table 129. Biogen Idec Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 130. Biogen Idec Oncology Small Molecule Drugs Product Offered
Table 131. Biogen Idec Main Business
Table 132. Biogen Idec Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 133. Biogen Idec Latest Developments
Table 134. Eisai Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 135. Eisai Oncology Small Molecule Drugs Product Offered
Table 136. Eisai Main Business
Table 137. Eisai Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 138. Eisai Latest Developments
Table 139. Teva Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 140. Teva Oncology Small Molecule Drugs Product Offered
Table 141. Teva Main Business
Table 142. Teva Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 143. Teva Latest Developments
Table 144. Otsuka Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 145. Otsuka Oncology Small Molecule Drugs Product Offered
Table 146. Otsuka Main Business
Table 147. Otsuka Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 148. Otsuka Latest Developments
Table 149. Ipsen Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 150. Ipsen Oncology Small Molecule Drugs Product Offered
Table 151. Ipsen Main Business
Table 152. Ipsen Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 153. Ipsen Latest Developments
Table 154. Gilead Sciences Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 155. Gilead Sciences Oncology Small Molecule Drugs Product Offered
Table 156. Gilead Sciences Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 157. Gilead Sciences Main Business
Table 158. Gilead Sciences Latest Developments
Table 159. Exelixis Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 160. Exelixis Oncology Small Molecule Drugs Product Offered
Table 161. Exelixis Main Business
Table 162. Exelixis Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 163. Exelixis Latest Developments
Table 1. Oncology Small Molecule Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Chemotherapy Drugs
Table 3. Major Players of Immunomodulating Drugs
Table 4. Major Players of Targeted Therapy Drugs
Table 5. Major Players of Hormonal Therapy
Table 6. Major Players of Other
Table 7. Oncology Small Molecule Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Oncology Small Molecule Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2022)
Table 10. Oncology Small Molecule Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Oncology Small Molecule Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2022)
Table 13. Global Oncology Small Molecule Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Oncology Small Molecule Drugs Revenue Market Share by Player (2020-2022)
Table 15. Oncology Small Molecule Drugs Key Players Head office and Products Offered
Table 16. Oncology Small Molecule Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oncology Small Molecule Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Oncology Small Molecule Drugs Market Size Market Share by Regions (2017-2022)
Table 21. Americas Oncology Small Molecule Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Oncology Small Molecule Drugs Market Size Market Share by Country (2017-2022)
Table 23. Americas Oncology Small Molecule Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2022)
Table 25. Americas Oncology Small Molecule Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2022)
Table 27. APAC Oncology Small Molecule Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Oncology Small Molecule Drugs Market Size Market Share by Region (2017-2022)
Table 29. APAC Oncology Small Molecule Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2022)
Table 31. APAC Oncology Small Molecule Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2022)
Table 33. Europe Oncology Small Molecule Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Oncology Small Molecule Drugs Market Size Market Share by Country (2017-2022)
Table 35. Europe Oncology Small Molecule Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2022)
Table 37. Europe Oncology Small Molecule Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Oncology Small Molecule Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Oncology Small Molecule Drugs Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Oncology Small Molecule Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Oncology Small Molecule Drugs Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Oncology Small Molecule Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Oncology Small Molecule Drugs Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Oncology Small Molecule Drugs
Table 46. Key Market Challenges & Risks of Oncology Small Molecule Drugs
Table 47. Key Industry Trends of Oncology Small Molecule Drugs
Table 48. Global Oncology Small Molecule Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Oncology Small Molecule Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Oncology Small Molecule Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Oncology Small Molecule Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Oncology Small Molecule Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Oncology Small Molecule Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 54. Roche Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 55. Roche Oncology Small Molecule Drugs Product Offered
Table 56. Roche Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Roche Main Business
Table 58. Roche Latest Developments
Table 59. Novartis Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 60. Novartis Oncology Small Molecule Drugs Product Offered
Table 61. Novartis Main Business
Table 62. Novartis Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Novartis Latest Developments
Table 64. Pfizer Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 65. Pfizer Oncology Small Molecule Drugs Product Offered
Table 66. Pfizer Main Business
Table 67. Pfizer Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Pfizer Latest Developments
Table 69. Celgene Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 70. Celgene Oncology Small Molecule Drugs Product Offered
Table 71. Celgene Main Business
Table 72. Celgene Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Celgene Latest Developments
Table 74. Bristol-Myers Squibb Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 75. Bristol-Myers Squibb Oncology Small Molecule Drugs Product Offered
Table 76. Bristol-Myers Squibb Main Business
Table 77. Bristol-Myers Squibb Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Bristol-Myers Squibb Latest Developments
Table 79. Amgen Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 80. Amgen Oncology Small Molecule Drugs Product Offered
Table 81. Amgen Main Business
Table 82. Amgen Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. Amgen Latest Developments
Table 84. Johnson & Johnson Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 85. Johnson & Johnson Oncology Small Molecule Drugs Product Offered
Table 86. Johnson & Johnson Main Business
Table 87. Johnson & Johnson Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Johnson & Johnson Latest Developments
Table 89. AbbVie Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 90. AbbVie Oncology Small Molecule Drugs Product Offered
Table 91. AbbVie Main Business
Table 92. AbbVie Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. AbbVie Latest Developments
Table 94. Sanofi Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 95. Sanofi Oncology Small Molecule Drugs Product Offered
Table 96. Sanofi Main Business
Table 97. Sanofi Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Sanofi Latest Developments
Table 99. Takeda Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 100. Takeda Oncology Small Molecule Drugs Product Offered
Table 101. Takeda Main Business
Table 102. Takeda Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Takeda Latest Developments
Table 104. Eli Lilly Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 105. Eli Lilly Oncology Small Molecule Drugs Product Offered
Table 106. Eli Lilly Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 107. Eli Lilly Main Business
Table 108. Eli Lilly Latest Developments
Table 109. Bayer Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 110. Bayer Oncology Small Molecule Drugs Product Offered
Table 111. Bayer Main Business
Table 112. Bayer Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 113. Bayer Latest Developments
Table 114. AstraZeneca Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 115. AstraZeneca Oncology Small Molecule Drugs Product Offered
Table 116. AstraZeneca Main Business
Table 117. AstraZeneca Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 118. AstraZeneca Latest Developments
Table 119. Astellas Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 120. Astellas Oncology Small Molecule Drugs Product Offered
Table 121. Astellas Main Business
Table 122. Astellas Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 123. Astellas Latest Developments
Table 124. Merck Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 125. Merck Oncology Small Molecule Drugs Product Offered
Table 126. Merck Main Business
Table 127. Merck Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 128. Merck Latest Developments
Table 129. Biogen Idec Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 130. Biogen Idec Oncology Small Molecule Drugs Product Offered
Table 131. Biogen Idec Main Business
Table 132. Biogen Idec Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 133. Biogen Idec Latest Developments
Table 134. Eisai Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 135. Eisai Oncology Small Molecule Drugs Product Offered
Table 136. Eisai Main Business
Table 137. Eisai Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 138. Eisai Latest Developments
Table 139. Teva Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 140. Teva Oncology Small Molecule Drugs Product Offered
Table 141. Teva Main Business
Table 142. Teva Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 143. Teva Latest Developments
Table 144. Otsuka Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 145. Otsuka Oncology Small Molecule Drugs Product Offered
Table 146. Otsuka Main Business
Table 147. Otsuka Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 148. Otsuka Latest Developments
Table 149. Ipsen Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 150. Ipsen Oncology Small Molecule Drugs Product Offered
Table 151. Ipsen Main Business
Table 152. Ipsen Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 153. Ipsen Latest Developments
Table 154. Gilead Sciences Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 155. Gilead Sciences Oncology Small Molecule Drugs Product Offered
Table 156. Gilead Sciences Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 157. Gilead Sciences Main Business
Table 158. Gilead Sciences Latest Developments
Table 159. Exelixis Details, Company Type, Oncology Small Molecule Drugs Area Served and Its Competitors
Table 160. Exelixis Oncology Small Molecule Drugs Product Offered
Table 161. Exelixis Main Business
Table 162. Exelixis Oncology Small Molecule Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 163. Exelixis Latest Developments
LIST OF FIGURES
Figure 1. Oncology Small Molecule Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Small Molecule Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Oncology Small Molecule Drugs Market Size Market Share by Type in 2021
Figure 7. Oncology Small Molecule Drugs in Blood Cancer
Figure 8. Global Oncology Small Molecule Drugs Market: Blood Cancer (2017-2022) & ($ Millions)
Figure 9. Oncology Small Molecule Drugs in Breast Cancer
Figure 10. Global Oncology Small Molecule Drugs Market: Breast Cancer (2017-2022) & ($ Millions)
Figure 11. Oncology Small Molecule Drugs in Gastrointestinal Cancer
Figure 12. Global Oncology Small Molecule Drugs Market: Gastrointestinal Cancer (2017-2022) & ($ Millions)
Figure 13. Oncology Small Molecule Drugs in Prostate Cancer
Figure 14. Global Oncology Small Molecule Drugs Market: Prostate Cancer (2017-2022) & ($ Millions)
Figure 15. Oncology Small Molecule Drugs in Lung Cancer
Figure 16. Global Oncology Small Molecule Drugs Market: Lung Cancer (2017-2022) & ($ Millions)
Figure 17. Oncology Small Molecule Drugs in Other
Figure 18. Global Oncology Small Molecule Drugs Market: Other (2017-2022) & ($ Millions)
Figure 19. Global Oncology Small Molecule Drugs Market Size Market Share by Application in 2021
Figure 20. Global Oncology Small Molecule Drugs Revenue Market Share by Player in 2021
Figure 21. Global Oncology Small Molecule Drugs Market Size Market Share by Regions (2017-2022)
Figure 22. Americas Oncology Small Molecule Drugs Market Size 2017-2022 ($ Millions)
Figure 23. APAC Oncology Small Molecule Drugs Market Size 2017-2022 ($ Millions)
Figure 24. Europe Oncology Small Molecule Drugs Market Size 2017-2022 ($ Millions)
Figure 25. Middle East & Africa Oncology Small Molecule Drugs Market Size 2017-2022 ($ Millions)
Figure 26. Americas Oncology Small Molecule Drugs Value Market Share by Country in 2021
Figure 27. Americas Oncology Small Molecule Drugs Consumption Market Share by Type in 2021
Figure 28. Americas Oncology Small Molecule Drugs Market Size Market Share by Application in 2021
Figure 29. United States Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Canada Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. Mexico Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Brazil Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. APAC Oncology Small Molecule Drugs Market Size Market Share by Region in 2021
Figure 34. APAC Oncology Small Molecule Drugs Market Size Market Share by Application in 2021
Figure 35. China Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 36. Japan Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. Korea Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 38. Southeast Asia Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. India Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. Australia Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Europe Oncology Small Molecule Drugs Market Size Market Share by Country in 2021
Figure 42. Europe Oncology Small Molecule Drugs Market Size Market Share by Type in 2021
Figure 43. Europe Oncology Small Molecule Drugs Market Size Market Share by Application in 2021
Figure 44. Germany Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. France Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 46. UK Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. Italy Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. Russia Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Middle East & Africa Oncology Small Molecule Drugs Market Size Market Share by Region in 2021
Figure 50. Middle East & Africa Oncology Small Molecule Drugs Market Size Market Share by Type in 2021
Figure 51. Middle East & Africa Oncology Small Molecule Drugs Market Size Market Share by Application in 2021
Figure 52. Egypt Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 53. South Africa Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 54. Israel Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 55. Turkey Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 56. GCC Country Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 57. Americas Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 58. APAC Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Europe Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Middle East & Africa Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 61. United States Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Canada Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Mexico Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 64. Brazil Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 65. China Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Japan Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Korea Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Southeast Asia Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 69. India Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 70. Australia Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Germany Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 72. France Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 73. UK Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 74. Italy Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 75. Russia Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 76. Spain Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 77. Egypt Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 78. South Africa Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 79. Israel Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 80. Turkey Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 81. GCC Countries Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 1. Oncology Small Molecule Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Small Molecule Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Oncology Small Molecule Drugs Market Size Market Share by Type in 2021
Figure 7. Oncology Small Molecule Drugs in Blood Cancer
Figure 8. Global Oncology Small Molecule Drugs Market: Blood Cancer (2017-2022) & ($ Millions)
Figure 9. Oncology Small Molecule Drugs in Breast Cancer
Figure 10. Global Oncology Small Molecule Drugs Market: Breast Cancer (2017-2022) & ($ Millions)
Figure 11. Oncology Small Molecule Drugs in Gastrointestinal Cancer
Figure 12. Global Oncology Small Molecule Drugs Market: Gastrointestinal Cancer (2017-2022) & ($ Millions)
Figure 13. Oncology Small Molecule Drugs in Prostate Cancer
Figure 14. Global Oncology Small Molecule Drugs Market: Prostate Cancer (2017-2022) & ($ Millions)
Figure 15. Oncology Small Molecule Drugs in Lung Cancer
Figure 16. Global Oncology Small Molecule Drugs Market: Lung Cancer (2017-2022) & ($ Millions)
Figure 17. Oncology Small Molecule Drugs in Other
Figure 18. Global Oncology Small Molecule Drugs Market: Other (2017-2022) & ($ Millions)
Figure 19. Global Oncology Small Molecule Drugs Market Size Market Share by Application in 2021
Figure 20. Global Oncology Small Molecule Drugs Revenue Market Share by Player in 2021
Figure 21. Global Oncology Small Molecule Drugs Market Size Market Share by Regions (2017-2022)
Figure 22. Americas Oncology Small Molecule Drugs Market Size 2017-2022 ($ Millions)
Figure 23. APAC Oncology Small Molecule Drugs Market Size 2017-2022 ($ Millions)
Figure 24. Europe Oncology Small Molecule Drugs Market Size 2017-2022 ($ Millions)
Figure 25. Middle East & Africa Oncology Small Molecule Drugs Market Size 2017-2022 ($ Millions)
Figure 26. Americas Oncology Small Molecule Drugs Value Market Share by Country in 2021
Figure 27. Americas Oncology Small Molecule Drugs Consumption Market Share by Type in 2021
Figure 28. Americas Oncology Small Molecule Drugs Market Size Market Share by Application in 2021
Figure 29. United States Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Canada Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. Mexico Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Brazil Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. APAC Oncology Small Molecule Drugs Market Size Market Share by Region in 2021
Figure 34. APAC Oncology Small Molecule Drugs Market Size Market Share by Application in 2021
Figure 35. China Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 36. Japan Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. Korea Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 38. Southeast Asia Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. India Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. Australia Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Europe Oncology Small Molecule Drugs Market Size Market Share by Country in 2021
Figure 42. Europe Oncology Small Molecule Drugs Market Size Market Share by Type in 2021
Figure 43. Europe Oncology Small Molecule Drugs Market Size Market Share by Application in 2021
Figure 44. Germany Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. France Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 46. UK Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. Italy Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. Russia Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Middle East & Africa Oncology Small Molecule Drugs Market Size Market Share by Region in 2021
Figure 50. Middle East & Africa Oncology Small Molecule Drugs Market Size Market Share by Type in 2021
Figure 51. Middle East & Africa Oncology Small Molecule Drugs Market Size Market Share by Application in 2021
Figure 52. Egypt Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 53. South Africa Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 54. Israel Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 55. Turkey Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 56. GCC Country Oncology Small Molecule Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 57. Americas Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 58. APAC Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Europe Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Middle East & Africa Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 61. United States Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Canada Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Mexico Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 64. Brazil Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 65. China Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Japan Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Korea Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Southeast Asia Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 69. India Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 70. Australia Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Germany Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 72. France Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 73. UK Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 74. Italy Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 75. Russia Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 76. Spain Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 77. Egypt Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 78. South Africa Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 79. Israel Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 80. Turkey Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
Figure 81. GCC Countries Oncology Small Molecule Drugs Market Size 2023-2028 ($ Millions)
